Immune Thrombocytopenia (ITP) Therapy
J15 · Effective Apr 1, 2020
2 active Medicare policies list 90283, and 21 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 1, 2020
National · Effective Apr 16, 2026
21 policies from 9 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 90283 |
|---|---|---|
| Alzheimer's Disease: Experimental, Investigational, or Unproven Treatments | Feb 20, 2024 | Covered |
| Guillain-Barre Syndrome Treatments | Sep 22, 2023 | Covered |
| Recurrent Pregnancy Loss | Feb 15, 2024 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss |
| Jan 1, 2026 |
| Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immunoglobulin Therapy | Jan 1, 2026 | Covered |
| Reproductive Techniques and Immunotherapy for Recurrent Fetal Loss | Jan 1, 2026 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Autism Spectrum Disorders/Pervasive Developmental Disorders: Assessment and Treatment | May 15, 2026 | Not covered |
| Policy | Effective | Status of 90283 |
|---|---|---|
| Immune Globulin (IVIG and SCIG) | Oct 1, 2026 | Covered |